Yale epidemiologist Harvey Risch, who has speculated about a connection between Covid vaccines and “turbo cancer” and promoted ivermectin, says he'll chair the President's Cancer Panel.
Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still haven’t finished.
At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a “men’s health crisis.” Others called to ease men’s access to hormones.
Most Democratic-led states will continue to recommend the hepatitis B vaccine at birth, despite a CDC advisory panel’s vote against it.
Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.
The author of Super Agers believes AI could bring big changes to the world of medicine.
ARMR Sciences of New York is trialing a vaccine in the Netherlands to protect against fentanyl-related overdose and death.
Everyone’s suddenly obsessed with the pelvic floor—physical therapists, MAHA influencers, me. Could this deeply misunderstood body part really be the seat of so much modern dysfunction?
Schools in the US are installing vape-detection tech in bathrooms to thwart student nicotine and cannabis use. A new investigation reveals the impact of using spying to solve a problem.
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
